GLYCOPRESS INDUS: Uses, Dosage, Side Effects, Price, and More…..
Jul 24, 2024
Chronic respiratory diseases are a growing health concern in India. Rising air pollution, smoking, exposure to biomass fuel, occupational dust, and recurrent respiratory infections have led to a steady increase in Chronic Obstructive Pulmonary Disease (COPD) cases across urban and rural populations. COPD is a progressive condition that affects breathing, daily activity, and overall quality of life if not managed properly.
GLYCOPRESS INDUS, formulated with Indacaterol Maleate Hemihydrate and Glycopyrronium Bromide (Glycopyrrolate IP) powder for inhalation 110 mcg / 50 mcg, is an advanced long-acting dual bronchodilator therapy designed for once-daily maintenance treatment of COPD. This combination helps patients breathe easier, remain active, and reduce the risk of exacerbations.
This comprehensive blog explains everything you need to know about GLYCOPRESS INDUS—its composition, mechanism of action, uses, benefits, dosage, safety profile, precautions, and patient guidance—in clear and easy-to-understand language.
Understanding COPD – A Major Respiratory Challenge in India
COPD is a chronic lung disease characterized by persistent airflow limitation. It includes conditions such as chronic bronchitis and emphysema. Unlike asthma, COPD is usually progressive and requires long-term maintenance therapy.
Common Causes of COPD
-
Cigarette smoking and tobacco use
-
Indoor air pollution from biomass fuels
-
Outdoor air pollution
-
Occupational exposure to dust and chemicals
-
Recurrent respiratory infections
-
Genetic susceptibility
Common Symptoms
-
Shortness of breath (especially during exertion)
-
Chronic cough
-
Excess mucus production
-
Chest tightness
-
Fatigue
-
Frequent respiratory infections
Early diagnosis and appropriate inhalation therapy play a crucial role in slowing disease progression and improving quality of life.
What is GLYCOPRESS INDUS?
GLYCOPRESS INDUS is a dry powder inhalation medicine containing a fixed-dose combination of:
-
Indacaterol Maleate Hemihydrate – 110 mcg
-
Glycopyrronium Bromide (Glycopyrrolate IP) – 50 mcg
It is primarily prescribed as a maintenance treatment for COPD in adult patients. This combination belongs to the LABA + LAMA category (Long-Acting Beta-2 Agonist + Long-Acting Muscarinic Antagonist), which is considered a cornerstone therapy for moderate to severe COPD.
Composition of GLYCOPRESS INDUS
Each dose delivers:
-
Indacaterol Maleate Hemihydrate 110 mcg
-
Glycopyrronium Bromide (Glycopyrrolate IP) 50 mcg
-
Pharmaceutical-grade excipients suitable for inhalation
This carefully balanced formulation ensures rapid onset of action, sustained bronchodilation, and 24-hour symptom control.
How GLYCOPRESS INDUS Works
GLYCOPRESS INDUS provides dual bronchodilation by targeting two different pathways responsible for airway narrowing.
Role of Indacaterol Maleate Hemihydrate (LABA)
Indacaterol is a long-acting beta-2 adrenergic agonist that relaxes airway smooth muscles.
Key Actions:
-
Rapid onset of bronchodilation
-
Keeps airways open for up to 24 hours
-
Reduces breathlessness
-
Improves exercise tolerance
-
Enhances lung function
Indacaterol is known for its fast onset and sustained action, making it ideal for once-daily dosing.
Role of Glycopyrronium Bromide (LAMA)
Glycopyrronium is a long-acting muscarinic antagonist that blocks acetylcholine-mediated bronchoconstriction.
Key Actions:
-
Prevents airway tightening
-
Reduces mucus secretion
-
Maintains airway openness throughout the day
-
Lowers risk of COPD exacerbations
Why Dual Bronchodilation Matters
In COPD, airway narrowing occurs due to multiple mechanisms. Using only one bronchodilator may not provide adequate control.
GLYCOPRESS INDUS:
-
Relaxes airway muscles (LABA action)
-
Prevents nerve-mediated bronchoconstriction (LAMA action)
-
Provides superior symptom relief compared to single-agent therapy
This dual approach leads to better breathing, fewer flare-ups, and improved daily functioning.
Uses of GLYCOPRESS INDUS
GLYCOPRESS INDUS is indicated for:
1. Chronic Obstructive Pulmonary Disease (COPD)
Used as a long-term maintenance therapy in patients with moderate to severe COPD.
2. Chronic Bronchitis
Helps reduce airflow limitation and breathlessness.
3. Emphysema
Improves lung ventilation and reduces air trapping.
4. Prevention of COPD Exacerbations
Regular use lowers the frequency and severity of flare-ups.
Benefits of GLYCOPRESS INDUS
-
Dual bronchodilation for superior airflow improvement
-
Once-daily dosing improves patient compliance
-
Rapid onset with long-lasting effect
-
Reduces breathlessness and chest tightness
-
Improves exercise capacity and daily activity
-
Lowers risk of COPD exacerbations
-
Direct lung delivery with minimal systemic side effects
Why Inhalation Therapy is Preferred in COPD
Inhalation therapy delivers medicine directly to the lungs, ensuring:
-
Faster onset of action
-
Lower required doses
-
Fewer systemic side effects
-
Better disease control
GLYCOPRESS INDUS, as a dry powder inhaler formulation, ensures efficient drug deposition in the airways.
Dosage and Administration
Recommended Dosage
-
One inhalation once daily, or as prescribed by the physician.
How to Use
-
Use the inhaler exactly as instructed
-
Do not swallow the powder
-
Inhale deeply and steadily
-
Use at the same time each day
Duration of Therapy
-
Long-term, maintenance treatment
-
Regular use is essential for best results
Do not stop the medicine without consulting your doctor.
Who Can Use GLYCOPRESS INDUS?
GLYCOPRESS INDUS is suitable for:
-
Adults diagnosed with COPD
-
Patients with persistent breathlessness
-
Individuals with frequent COPD exacerbations
-
Patients requiring long-acting bronchodilator therapy
Not recommended for children or for asthma unless specifically prescribed.
Possible Side Effects
Most patients tolerate GLYCOPRESS INDUS well.
Common Side Effects
-
Dry mouth
-
Cough
-
Throat irritation
-
Headache
Less Common Side Effects
-
Palpitations
-
Dizziness
-
Nasal congestion
Rare Side Effects
-
Allergic reactions
-
Urinary retention (in susceptible patients)
If side effects persist or worsen, seek medical advice.
Precautions and Warnings
-
Not for acute breathing attacks
-
Use cautiously in patients with heart disorders
-
Inform your doctor if you have glaucoma or prostate problems
-
Avoid exceeding prescribed dose
-
Always demonstrate correct inhaler technique
Use During Pregnancy and Breastfeeding
-
Should be used only if clearly needed
-
Doctor will assess benefit versus risk
-
Inform your physician if pregnant or breastfeeding
Drug Interactions
Inform your doctor if you are taking:
-
Other bronchodilators
-
Beta-blockers
-
Anticholinergic medicines
-
Medicines for heart rhythm disorders
Lifestyle Measures to Support COPD Management
-
Quit smoking completely
-
Avoid air pollution and dust exposure
-
Use protective masks when needed
-
Follow pulmonary rehabilitation programs
-
Maintain regular physical activity
-
Get vaccinated against flu and pneumonia
Why Choose GLYCOPRESS INDUS?
GLYCOPRESS INDUS stands out because:
-
Proven LABA + LAMA combination
-
Once-daily convenience
-
Long-lasting symptom control
-
Improved lung function and quality of life
-
Suitable for Indian COPD patients
It offers a modern, guideline-recommended approach to COPD management.
Conclusion
GLYCOPRESS INDUS, containing Indacaterol Maleate Hemihydrate 110 mcg and Glycopyrronium Bromide 50 mcg powder for inhalation, is a reliable and effective dual bronchodilator therapy for COPD. By addressing airflow limitation through two complementary mechanisms, it provides sustained symptom relief, improves daily activity, and reduces the risk of exacerbations.
Frequently Asked Questions
Is GLYCOPRESS INDUS a steroid inhaler?
No. It does not contain steroids. It is a dual bronchodilator (LABA + LAMA).
Can it be used daily?
Yes. It is designed for once-daily maintenance therapy.
Does it provide instant relief?
It helps improve breathing quickly but is not a rescue inhaler.
Is it safe for long-term use?
Yes, when used as prescribed under medical supervision.
Can it be combined with inhaled steroids?
Yes, if advised by the doctor in severe COPD cases.
If You Want To Purchase The Product Click Here.
We Have Our Asthma Range.
Recent Post
What to Expect When Taking Opipramol 100 mg: A First-Timer’s Guide
How Do Empagliflozin, Linagliptin, and Metformin ER Work Together for Diabetes Control?
Why Doctors Prescribe Pregabalin with Epalrestat and Methylcobalamin for Nerve Pain Steris Healthcare.
Steris Healthcare Pvt Ltd Radiates Excellence at the Dec 2025 ZEE Media Global Innovation & Leadership Summit, London!
Terbinafine 250mg & Itraconazole 100mg: The Ultimate Solution for Stubborn Fungal Infections Steris Healthcare.
Understanding Nebivolol 5mg & S-Amlodipine 2.5mg: A Powerful Combo for Heart Health
FLAVOSHIELD 500: The Complete Guide to Micronized Purified Flavonoid Fraction for Venous Health Steris Healthcare.
Unlocking Relief: How Egolix 150mg Treats Endometriosis Pain Steris Healthcare.
Isosorbide Mononitrate 60 mg in Long-Term Angina Management: Role and Best Practices Steris Healthcare.
How Ribavirin Capsules Help in Treating Chronic Viral Infections Steris Healthcare.